Takeda Pharmaceutical Co., Ltd. et al v. TWi Pharmaceuticals, Inc.

Filing 167

CASE MANAGEMENT ORDER. Signed by Judge Lucy H. Koh on 4/9/2015. (lhklc3S, COURT STAFF) (Filed on 4/9/2015)

1
2
3
4
5
UNITED STATES DISTRICT COURT
NORTHERN DISTRICT OF CALIFORNIA
SAN JOSE DIVISION

6
7

9

TAKEDA PHARMACEUTICAL CO., LTD.,
TAKEDA PHARMACEUTICALS U.S.A.,
INC., AND TAKEDA
PHARMACEUTICALS AMERICA, INC.,

10

Plaintiffs,

United States District Court
For the Northern District of California

8

11
12

v.
TWI PHARMACEUTICALS, INC.,
Defendant.

13

)
)
)
)
)
)
)
)
)
)
)
)
)

Case No.: 13-CV-02420-LHK
CASE MANAGEMENT ORDER

14
15

Plaintiffs’ Attorneys: Jeffrey Weinberger; Ted Dane; Heather Takahashi; John Schwab
Defendant’s Attorneys: Don J. Mizerk; John Sholar

16
A case management conference was held on April 9, 2015.
17
18
19

Each side is limited to four (4) motions in limine. Each motion and opposition shall not
exceed five (5) pages in length. The parties may not file replies.
The parties stipulated to shorten the length of trial to five (5) days. Accordingly, the case
schedule is as follows:

20
Scheduled Event

Date

22

Deadline for Takeda to File and Serve a Narrowed List of
Asserted Claims

April 16, 2015
(max 5 claims)

23

Final Pretrial Conference

May 14, 2015, at 1:30 p.m.

Bench Trial

June 2, 2015, at 9:00 a.m.

Length of Trial

5 days

21

24
25
26
27

IT IS SO ORDERED.
Dated: April 9, 2015

_________________________________
LUCY H. KOH
United States District Judge

28
1
Case Nos.: 13-CV-02420-LHK
CASE MANAGEMENT ORDER